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Commentary
Air pollution exists as a complex mixture that 
varies spatially and temporally in its charac­
teristics. In the United States and other 
countries, major air pollutants are regulated 
individually, although when present in a 
mixture, their toxicity could differ from that 
found in investigations directed at individual 
pollutants. As recommended by the National 
Research Council (NRC 2004a), there is 
increasing interest in managing environmen­
tal air quality using multipollutant strategies 
aimed at reducing the aggregate health bur­
den of air pollution. Therefore, from both 
the public health and regulatory perspectives, 
the potential for synergy among mixture 
components is a particular concern. A fair 
and increasingly frequent question is whether 
there are any documented examples of syner­
gies among air pollutants. That question was 
the focus of our review and this commentary.
Definitions and strategies. Synergy is 
strictly defined as occurring if the effect of the 
combined exposure is greater than the sum 
of the effects of the two or more individual 
components of the mixture (see definitions 
in Appendix 1). The term is used loosely and 
sometimes applied to any effect of a combi­
nation of pollutants that is greater than the 
effect of one of the components alone. This 
circumstance is not an instance of synergy as 
defined within the public health community 
unless the effects are greater than additive. 
The term also extends to an effect caused by a 
combination of pollutants but not caused by 
exposure to the individual pollutants, absent 
exposure to the others. This applied defini­
tion makes clear the need to have evidence 
on both the individual and the combined 
effects of any combination of pollutants to 
evaluate the presence of synergism.
The term “interaction” also requires a 
careful definition. As defined in statistical 
modeling, interaction refers to the inter­
dependence of the effects of two or more 
variables. Product terms of the potentially 
interacting variables are inserted into ana­
lytical models to test for the presence of 
interaction, which may be synergistic or 
antagonistic. The statistical tests for inter­
action have low statistical power, and con­
sequently the joint effects of several factors 
may be only imprecisely characterized, unless 
there is a strong interaction or abundant 
data. Often, the term “interaction” is used 
loosely to refer to synergism or antagonism, 
although more accurately, interactions can be 
characterized as synergistic or antagonistic, 
depending on the direction of the combined 
effect. Epidemiologists also use the term 
“effect modification” to refer to interdepen­
dence of the effects of two or more variables 
(Last 2000). 
Synergism between two environmental 
pollutants might occur through a variety of 
mechanisms. First, the two pollutants might 
act at the same or different steps in the same 
mechanistic pathway; second, the presence 
of one might influence ability to mitigate the 
action of the other; and third, the presence 
of one might influence the dose of the other. 
There are the possibilities that the existence 
of synergism could be dose dependent, that 
the same combined exposure might be syn­
ergistic for one effect and not for others, or 
that the same effect may be synergistic in 
some tissues and not in others, as illustrated 
by examples presented later.
Laboratory and epidemiologic studies 
have demonstrated effects of combined or 
sequential exposures that were greater than 
the effects of either exposure given singly, but 
the combined effects were often simply addi­
tive. Other such studies have demonstrated 
combined effects that were less than additive. 
A strict quantitative test of synergy requires 
measurement of the effects of each com­
ponent and of the combined components 
administered under identical conditions. For 
environmental exposures studied with epide­
miologic methods, the corresponding condi­
tions would include sufficiently comparable 
populations, measurements of effect, coex­
posures to other pollutants, and other modi­
fying factors. Such identical conditions are 
impossible to achieve in the strictest sense, 
but may be approximated to varying degrees 
in epidemiologic studies through careful 
design and analysis. 
In assessing synergism among pollutants 
using epidemiologic approaches, the mini­
mum information needed is estimation of 
exposure or dose for the two or more pollut­
ants under investigation. Most often, syner­
gism is assessed using multivariable models 
that include terms representing the effects 
of the individual pollutants and one or more 
interaction terms that represent potential 
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joint effects (Greenland 1983; Rothman et al. 
2008). A model for two pollutants would be 
as follows:
  Y = α + β1x1 + β2x2 + β3x1x2 + ε ,  [1]
where Y is the outcome, x1 and x2 are two 
specific pollutants, β1 and β2 estimate the 
pollutant­specific effects of x1 and x2, and β3 
estimates the joint effect of x1 and x2, and ε is 
the error term. In the presence of inter  action 
(synergism is positive interaction), β3 is not 
zero, the value indicating no interaction, and 
the effect of x1 is x1(β1 + β3x1x2) and that 
of x2 is x2(β2 + β3x1x2). In the example of 
smoking, radon exposure, and lung cancer, 
Y might represent risk for lung cancer death, 
x1 the cumulative amount smoked, and x2 the 
cumulative exposure to radon. For three pol­
lutants, there are three two­way interaction 
terms (for x1x2, x1x3, and x2x3) as well as a 
three­way interaction term for x1x2x3. As the 
number of potentially interacting pollutants 
increases, the number of possible interaction 
terms increases progressively. The coefficients 
are estimated by the algorithm used to fit the 
model to the data—for example, least squares 
or maximum likelihood. 
Even for two exposures, statistical power 
is limited for detecting interactions, and the 
value of β3 is estimated with limited preci­
sion, unless the data are substantial or there 
is particularly strong synergism (Greenland 
1983; Rothman et al. 2008). If inter­
actions among three or more pollutants are 
of interest, power is likely to be extremely 
limited, given the number of terms in the 
model. Interpretation of models directed at 
interaction also needs to consider error in 
the measurement of the pollutants and the 
consequences of errors that are differential 
among the pollutants. A further consider­
ation is the scale on which the interaction is 
assumed to take place: additive or multiplica­
tive. Typically, additive models are used for 
continuous outcome measures, such as lung 
function level, whereas multiplicative models 
are used for risk for events, such as prob­
ability of dying. Interpretation of interaction 
terms is scale dependent, although for public 
health purposes, epidemiologists are in con­
sensus that positive departure from additivity 
constitutes synergism (Rothman et al. 2008). 
Although the scale of interaction should be 
based in biological understanding, there is 
not a specific correspondence between bio­
logical interaction and statistical interaction 
in the modeling of epidemiologic data.
In the laboratory, evaluating synergism 
between pollutants A and B, for example, 
would require four exposure scenarios: a) con­
trol, b) A alone, c) B alone, and d) A + B 
(each at the same concentration as when 
given singly). Either the same or different 
groups of subjects might receive each treat­
ment, depending on the nature of the treat­
ment, persistence of effects, and meas  ure  ment 
methods.
Background knowledge. The Health 
Effects Institute convened a working group 
during 1990–1992 to review the subject 
(Samet and Speizer 1993a), and information 
in the resulting papers described challenges 
and strategies for evaluating complex mix­
tures by epidemiologic (Dockery 1993; Samet 
and Speizer 1993b; Weiss 1993) and labora­
tory studies (Mauderly 1993; McDonnell 
1993). The NRC and other organizations 
have convened numerous committees on the 
related topic of complex mixtures. Beyond 
subsequent reports of several laboratory stud­
ies examining interactions among pollutants 
at high doses, it is not clear that the under­
standing of synergistic interactions among 
environmental pollutants has advanced sub­
stantially beyond the 1993 reports. 
Synergisms among occupational inhala­
tion exposures are known; perhaps the best 
documented example is the synergy between 
radon progeny and cigarette smoking in pro­
ducing lung cancer in underground miners 
(NRC 1988, 1999). In this example, the 
presence of synergism was shown by a pooled 
analysis of data that contained information 
from cohorts of underground miners on both 
exposure to radon progeny and smoking. 
Statistical models were used to estimate the 
degree of synergism, which could be deter­
mined with reasonable precision because 
substantial data were available. Well­studied 
examples of potential synergism between 
smoking and other disease risk factors include 
asbestos and lung cancer [Agency for Toxic 
Substances and Disease Registry (ATSDR) 
2006; Selikof et al. 1968] and oral contra­
ceptives and pulmonary thromboembolism 
(Lidegaard 1999; Petitti et al 1996).
A review by the ATSDR of the toxico­
logic and epidemiologic literature on effects 
of mixtures (ATSDR 2004) found some, but 
scant, evidence for synergisms from exposures 
to multiple chemical agents. In addition to 
examples in which each component caused 
measurable effects, examples were cited in 
which combined exposures caused measurable 
effects that were not observed when the com­
ponents were administered individually at the 
same doses. Among the combined exposures 
reviewed by ATSDR, the effects were more 
commonly less than additive, rather than 
greater than additive. 
The air pollution literature yields similarly 
mixed results. For example, Chen et al. (1991) 
observed greater than additive effects on the 
pulmonary function of guinea pigs from expo­
sure to sulfuric acid (H2SO4), acid­coated 
zinc oxide particles, and ozone. Kleinman 
et al. (2000) observed less than additive effects 
on the proliferation of the respiratory epithe­
lium of rats exposed to O3, carbon particles, 
and ammonium bisulfate given singly and 
combined. Anderson and Avol (1992) did not 
find significant synergy between the effects 
of carbon particles and H2SO4 on the respi­
ratory function of experimentally exposed 
humans; however, the combination elicited 
effects in some subjects having no response to 
either carbon or acid alone, suggesting pos­
sible synergy. Jakab and Hemenway (1994) 
found that the effects of inhaled O3 and car­
bon black were synergistic in causing lung 
inflammation and suppressing phagocytosis 
by alveolar macrophages recovered from rats 
in bronchoalveolar lavage fluid (BALF). The 
effects of carbon black and O3 were syner­
gistic only when inhaled together, not when 
administered sequentially. Creutzenberg et al. 
(1995) found the combined effect of inhaled 
O3 and instilled carbon black on the uptake 
of particles by cells collected from exposed 
rats in BALF to be less than additive, but the 
effect on the migration of cells in response to 
a chemoattractant was synergistic. The latter 
two studies demonstrated that effects of com­
bined and sequential exposures might differ 
and that the same exposure may be synergistic 
for some, but not all, outcomes.
There have also been studies of interac­
tions between air pollutants and other agents, 
and these, too, have produced mixed results. 
For example, Spannhake et al. (2002) found 
a greater than additive release of the proin­
flammatory cytokine interleukin­8 from the 
BEAS­2B human airway epithelial cell line 
treated with rhinovirus and exposed to either 
O3 or nitrogen dioxide. Harrod et al. (2003) 
found less than additive effects on broncho­
alveolar lavage cell counts, proinflammatory 
cytokines, and Clara cell secretory protein 
levels in mice exposed to respiratory syncytial 
virus and diesel emissions. One could also 
consider many of the studies of the effects of 
pollutant exposure on airway reactivity as tests 
of synergy, if they include exposures to the 
pollutant and the airway agonist alone as well 
as in combination. For example, several of the 
29 studies listed in Table AX6­11 (Airway 
Responsiveness Following Ozone Exposure) 
of the most recent U.S. Environmental 
Protection Agency (EPA) Criteria Document 
for O3 (U.S. EPA 2006) fall into this cat­
egory, and by strict definition, demonstrate 
synergy between O3 and the airway agonist.
Review of Combined Exposure 
Studies Cited in 2006 U.S. EPA 
Ozone Criteria Document
The above studies indicate that synergies 
involving environmental air pollutants have 
been demonstrated in the laboratory and 
that O3 has been a component of synergistic 
combinations of pollutants. We turned to Synergy and air pollution
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the 2006 U.S. EPA Criteria Document for 
O3 (U.S. EPA 2006) to examine in detail a 
larger set of studies of combined exposures 
involving O3. This subset of the air pollution 
literature is a potentially informative body of 
evidence because it has been assembled in a 
policy­directed document. O3 is a common 
pollutant that has been studied extensively in 
population and laboratory settings, and the 
three tables encompass a sizable number of 
studies addressing the combined effects of O3 
and other pollutants. The original publica­
tions were examined to determine whether 
the study designs provided tests of synergy 
and, if so, whether a positive departure from 
additivity was demonstrated. The 14 studies 
we found to demonstrate synergies are listed 
in Table 1.
We did not attempt a more comprehen­
sive review of the air pollution literature, 
although such a review would be useful. 
People are certainly exposed to a wide spec­
trum of additional pollutant combinations, 
and the effects of some internally complex 
pollutant classes such as particulate matter 
(PM) may involve synergisms among com­
ponents. We found that our limited review 
was sufficient to solidly confirm the answer to 
the question of whether synergies among pol­
lutants found in the environment had been 
demonstrated. 
Laboratory studies of humans exposed to 
combinations including O3. We examined 
19 papers cited in Table AX6­14 (Ozone 
Mixed with Other Pollutants) of the 2006 
U.S. EPA Criteria Document. We found that 
the designs of 13 of 19 studies demonstrat­
ing significant effects were adequate to test 
for synergy. Only the following two studies 
(Table 1) demonstrated effects of combined 
exposures to O3 and another pollutant that 
were greater than the sum of the effects of the 
individual pollutants. The other 11 studies 
testing for synergy did not demonstrate effects 
that were greater than additive.
Horvath et al. (1986) exposed young, 
nonsmoking women for 2 hr during intermit­
tent exercise to 485 ppb O3, to 2 ppb peroxy­
acetyl nitrate (PAN), and to the combination 
of O3 and PAN. Measurements included 
heart rate, breathing pattern, lung volumes, 
forced exhalation, and O2–CO2 exchange. 
PAN alone caused some symptoms but either 
no or very small, insignificant effects among 
measured variables. O3 caused more reports 
of symptoms and significant effects on several 
measured variables. The combined exposure 
was additive with respect to total reported 
symptoms but greater than additive for 
most affected variables. For example, forced 
vital capacity near the end of exposure was 
reduced 2% by PAN, 23% by O3, and 31% 
by the combination, indicating a combined 
effect 24% greater than additive.
Drechsler­Parks (1995) exposed healthy 
older adults (five men and one woman, 
56–85 years of age, completed the proto­
col) for 2 hr during intermittent exercise to 
450 ppb O3, 600 ppb NO2, or to O3 and 
NO2 combined. Measurements included 
respiration, heart rate, cardiac output, and 
stroke volume. Cardiac output was increased 
1% by O3, reduced 5% by NO2, and reduced 
14% by the combination. Stroke volume was 
reduced 2% by O3, reduced 7% by NO2, 
and reduced 12% by the combination. These 
results suggest modest synergy. 
Laboratory studies of animals exposed 
to combinations including O3. We exam­
ined 17 papers listed as reporting synergis­
tic effects in Tables AX5­17 (Interactions 
of Ozone with Tobacco Smoke) and AX5­
18 (Interactions of Ozone with Particles) of 
the U.S. EPA Criteria Document (U.S. EPA 
2006). We found that only 14 of 17 stud­
ies were designed to test for synergism, and 
that only the 12 listed in Table 1 actually 
demonstrated synergism by reporting effects 
of combined exposures that were greater than 
the sum of effects of the individual exposures. 
This discrepancy between the authors’ con­
clusions and our review reflects the common 
tendency to use the term “synergism” loosely. 
The 12 studies demonstrating synergism for 
at least one measured outcome are described 
briefly here.
Two studies examined interactions 
between O3 and acid aerosols. Kimmel et al. 
(1997) exposed Sprague­Dawley rats 4 hr/
day for 2 days to O3 at 600 ppb, to fine 
(300 nm) or ultrafine (60 nm) H2SO4 aero­
sol at 500 µg/m3, or to the combinations of 
O3 and each of the acid aerosols and per­
formed morphometric measurements of cell 
proliferation and damage to alveolar septa. 
The volume percentage of markedly damaged 
alveolar tissue was only slightly increased by 
either acid exposure but markedly increased 
by O3. The combined effects were greater 
than additive. A similar pattern was observed 
for cell proliferation, but the degree of syn­
ergy was less pronounced.
Sindhu et al. (1998) exposed Fischer­344 
(F344) rats 4 hr/day, 3 days/week for 40 weeks 
to O3 at 150 ppb, nitric acid (HNO3) at 
50 µg/m3, or the combination, and meas  ured 
the lung content of polyamines. O3, but not 
HNO3, increased lung putrescine, and the 
combined effect was 2­fold greater than the 
O3 effect. Both exposures also increased lung 
spermidine and spermine contents, but the 
combined effects were less than additive.
Two studies examined interactions 
between O3 and aerosols of resuspended 
PM collected in Ottawa, Ontario, Canada. 
Vincent et al. (1997) exposed F344 rats 
for 4 hr to either 800 ppb O3; 5,000 or 
48,000 µg/m3 of resuspended urban PM 
from Ottawa (EHC­93); or to the combina­
tion of O3 and each concentration of par­
ticles. They evaluated cell proliferation in the 
lung parenchyma and bronchiolar region by 
cell labeling. Only O3 increased cell labeling 
when given alone. The combined effects were 
synergistic for labeling in the bronchioles but 
Table 1. Studies demonstrating synergy between O3 and other pollutants.
Subject  O3  Other exposure  Synergistic effect  Reference
Young adult women  480 ppb × 2 hr  270 ppb peroxyacetyl nitrate × 2 hr  Forced expiratory variables  Horvath et al. 1986
Older men and women  450 ppb × 2 hr  600 ppb NO2 × 2 hr  Cardiac output and stroke volume  Drechsler-Parks 1995
Rat  600 ppb × 4 hr × 2 days  500 µg/m3 0.3 µm   Alveolar epithelial proliferation  Kimmel et al. 1997
     H 2SO4 × 4 hr × 2 days   
    500 µg/m3 0.06 µm  Volume density of injured alveoli
     H 2SO4 × 4 hr × 2 days 
Rat  150 ppb × 4 hr × 3 days × 40 weeks  50 µg/m3 HNO3 × 4 hr × 3 days × 40 wk  Lung polyamines  Sindhu et al. 1998
Rat  800 ppb × 4 hr  5,000 or 48,000 µg/m3 resuspended urban PM  Lung cell proliferation  Vincent et al. 1997
Rat  800 ppb × 4 hr  57,000 µg/m3 resuspended urban PM  Lung cell proliferation  Adamson et al. 1999
Guinea pig  1,500 ppb × 1 hr  2 puffs of 33% cigarette smoke  Dynamic lung compliance and resistance  Wu et al. 1997
Mouse  500 ppb × 24 hr  30,000 µg/m3 sidestream cigarette smoke  Bronchoalveolar lavage cells and TNFα  Yu et al. 2002
     × 6 hr × 3 days 
Mouse  1,000 ppb × 24 hr  37.5 EU endotoxin × 10 min  Bronchoalveolar lavage IL-1 and IL-6  Johnston et al. 2002
Rat  500 ppb × 8 hr × 3 days  100 µg intranasal endotoxin × 2 days  Nasal epithelial mucosubstance  Fanucchi et al. 1998
Rat  500 ppb × 8 hr × 3 days  100 µg intranasal endotoxin × 2 days  Nasal epithelial mucosubstance  Wagner et al. 2001a
Rat  500 ppb × 8 hr × 3 days  100 µg intranasal endotoxin × 2 days  Nasal epithelial mucosubstance  Wagner et al. 2001b
Rat  500 ppb × 8 hr × 2 days  2 or 20 µg intranasal endotoxin × 2 days  Bronchoalveolar lavage neutrophils  Wagner et al. 2003
Rat  500 ppb × 8 hr × 3 days  50 µL intranasal 1% ovalbumin × 3 days  Nasal epithelial mucosubstance  Wagner et al. 2002Mauderly and Samet
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approximately additive for labeling in whole­
lung parenchyma. 
Adamson et al. (1999) exposed F344 rats 
for 4 hr to either 800 ppb O3, 57,000 µg/m3 
PM, or to the combination and evaluated cell 
proliferation in the whole lung and alveolar 
duct region by cell labeling. As in the former 
study, only O3 increased cell labeling when 
given alone, and the combined effects were 
approximately additive for whole­lung label­
ing; however, the effect was clearly synergis­
tic (approximately 4­fold) for labeling in the 
alveolar duct region. 
Two studies examined interactions between 
O3 and cigarette smoke, a complex mixture 
encountered in indoor and outdoor environ­
ments. Wu et al. (1997) exposed guinea pigs 
to a few breaths (two puffs) of diluted cigarette 
smoke followed by exposure to 1,500 ppb O3 
for 1 hr and then measured dynamic lung com­
pliance and resistance. The effects of smoke 
and O3 alone were compared with the effects 
of the sequential combination. Compliance 
was reduced by both exposures, and the com­
bined effect was slightly greater  than additive. 
Resistance was increased only by smoke when 
exposures were given singly, but the increase 
due to combined exposure was approximately 
10­fold greater than the effects of smoke alone.
Yu et al. (2002) exposed B6C3F1 mice 6 hr/
day for 3 days to aged, diluted side­stream ciga­
rette smoke at 30,000 µg PM/m3 and then to 
500 ppb O3 for 24 hr, or to the two pollutants 
alone, followed by measurement of centriacinar 
cell proliferation and markers of inflammation 
in BALF. Both exposures increased BALF neu­
trophils, and the combined effect was decid­
edly greater than additive. Neither exposure 
increased BALF lymphocytes, but the com­
bined exposure elicited a nearly 2­fold increase 
over control levels. The effects on BALF tumor 
necrosis factor alpha were slightly synergistic, 
and the effects on BALF interleukin­8 and cell 
proliferation were additive.
Five studies examined interactions between 
O3 and endotoxin. Although endotoxin is not 
a commonly measured air pollutant, it is ubiq­
uitous in the environment and a frequent com­
ponent of environmental PM. Johnston et al. 
(2002) exposed C57BL6J mice for 24 hr to O3 
at 1,000 ppb, to aerosolized endotoxin at an esti­
mated lung dose of 37.5 EU, or to O3 followed 
by endotoxin, and measured responses in BALF 
at 4 and 24 hr. At 4 hr, there were slightly syn­
ergistic increases in interleukin­1β and inter­
leukin­6, an additive effect on interleukin­1Ra, 
and less than additive effects on interleukin­1α 
and macrophage inhibitory factor. However, 
the effects on all of the markers were slightly to 
markedly synergistic at 3 days.
One group reported three different stud­
ies using identical sequences of exposure 
to O3 followed by intranasal instillation of 
endotoxin, including groups receiving the 
individual treatments. Fanucchi et al. (1998) 
exposed F344 rats 8 hr/day for 3 days to 
500 ppb O3 followed by two daily intrana­
sal instillations of endotoxin and evaluated 
nasal tissues by immunohistochemistry and 
RNA analysis at 3 hr or 6 days. Endotoxin 
alone had little effect on the volume density 
of AB/PAS­staining mucosubstances, but O3 
increased staining. The combined effect was 
somewhat synergistic at 6 hr and strikingly 
synergistic (> 6­fold) at 3 days after exposure. 
The effect on expression of the rMuc-5AC 
gene was approximately additive at 6 hr, but 
synergistic (3­fold) at 3 days. Using the same 
exposure protocol in two subsequent studies 
of F344 rats, Wagner et al. (2001a, 2001b) 
demonstrated the repeatability of the syner­
gistic effect on nasal mucosubstances.
In another study by the same group, 
Wagner et al. (2003) exposed F344 rats 8 hr/
day for 2 days to 1,000 ppb O3 , preceded 
each day by intranasal instillation of 2 or 
20 µg endotoxin, and included groups receiv­
ing the individual treatments. Three days later, 
they examined effects in the lung by analysis 
of BALF and changes in airway epithelium. 
The exposures produced synergistic increases 
in BALF neutrophils, mucin glycoprotein, 
and elastase, and also in intraepithelial muco­
substances and epithelial cell density in distal 
airways. Increases in BALF lymphocytes and 
macrophages were approximately additive, and 
the effect on epithelial cell density in proximal 
airways was less than additive. 
One study examined interactions between 
O3 and ovalbumin instilled intranasally. 
Wagner et al. (2002) exposed Brown Norway 
rats to 500 ppb O3 for 1 or 3 days and 
instilled 50 µL 1% ovalbumin after each O3 
exposure. At 24 hr after the last treatment, 
they examined inflammatory and epithelial 
cell populations, the volume densities of intra­
epithelial mucosubstances, and cell prolifera­
tion rates in nasal epithelium. The effect of 
O3 and antigen on epithelial mucosubstances 
was synergistic in the maxilloturbinates but 
less than additive in the septum. The effect on 
eosinophil influx was also synergistic in the 
maxilloturbinates but less than additive in the 
septum. The combined effects were less than 
additive for neutrophil influx, cell labeling, 
and epithelial cell density.
Summary, Discussion, and 
Conclusions
Our examination of studies cited in the 2006 
O3 Criteria Document (U.S. EPA 2006) con­
firmed that synergisms between O3 and other 
pollutants have been demonstrated in labora­
tory studies involving humans and animals. 
Fourteen studies among the 13 human and 
14 animal studies testing for synergy demon­
strated greater than additive effects for one or 
more outcomes. The co­pollutants in these 
studies included urban PM, cigarette smoke, 
H2SO4, HNO3, NO2, PAN, endotoxin, and 
antigen. These co­pollutants are all plausible 
classes of environmental air contaminants 
(accepting the neoantigen ovalbumin as a 
model for environmental proteinaceous anti­
gens). The additional studies not contained 
in the 2006 O3 Criteria Document, but cited 
above as examples of synergy involving O3, 
included carbon black, virus, and airway ago­
nists. This limited review, therefore, identi­
fied diverse examples of synergies between 
O3 and other air pollutants, as well as syner­
gies involving combinations of H2SO4 with 
carbon particles, and diesel emissions with 
virus. Of course, environmental exposures 
involve much more complex mixtures than 
those typically used in the laboratory. The 
studies we reviewed involved only a very few 
of the myriad pollutants encountered in the 
environment in different combinations. Only 
the studies including tobacco smoke or die­
sel emissions approached a realistic level of 
complexity, and only Kleinman et al. (2000) 
used a factorial design to examine the single 
and combined effects of more than two treat­
ments (they included three).
Differences in dose and dose pattern are 
key caveats in extrapolating these laboratory 
findings to environmental exposures. Nearly all 
of the laboratory studies involved high concen­
trations that are not reflective of typical envi­
ronmental exposures. The studies of humans 
involved 2­hr exposures to 450–485 ppb O3 
and concentrations of PAN and NO2 much 
higher than ambient levels in the United States. 
The O3 exposures of animals ranged from 150 
to 1,500 ppb, and only the study by Sindhu 
et al. (1998) included exposures longer than 
3 days. In that study, the exposure of rats 4 
hr/day, 3 days/week for 40 weeks to 150 ppb 
O3 ± 50 µg/m3 HNO3 used concentrations of 
O3 only twice the current 1­hr U.S. National 
Ambient Air Quality Standard (U.S. EPA 
2008), but a concentration of HNO3 many­
fold higher than is typical of the environment. 
The publications provide no indication as to 
whether any of these research groups have 
explored the dose–response relationships of 
their published findings down to environmental 
exposure levels. Unfortunately, the limitation 
posed by the range of exposure concentrations 
is a widespread issue in interpreting toxicology 
studies of air pollution and not only studies of 
combined exposures.
Existing information yields little indica­
tion of whether synergies observed in animals 
might also occur in humans, in animals of 
other species, in animals of other strains of 
the same species, or in subjects of different 
ages. Interspecies, interstrain, and age­related 
differences exist in the uptake and metabo­
lism of inhaled materials and in the suscep­
tibility and sensitivity to adverse effects. The Synergy and air pollution
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fact that more animal than human studies 
in our review demonstrated synergies can­
not be interpreted to mean that synergies are 
less likely to occur in humans. Our limited 
survey revealed no studies in which different 
species, strains, or ages were exposed to the 
same combinations of pollutants. Like the 
dose issue, the lack of systematic comparisons 
among research models is a prevalent limita­
tion throughout the air pollution literature.
The current evidence for synergism is 
restricted primarily to subclinical responses. 
The outcomes for which synergism was 
demonstrated in the studies described 
above encompassed a diverse spectrum of 
responses, including indicators of activated 
gene expression (e.g., Muc5AC), chemopro­
tective responses (e.g., lung polyamines), 
proinflammatory cytokines (e.g., interleu­
kins), frank inflammation (e.g., BALF neu­
trophils), alterations of cellular populations 
and functions (e.g., epithelial proliferation, 
increased mucosubstances), and alterations 
of organ­level function (e.g., cardiac out­
put, forced vital capacity). Although these 
effects reflect perturbations of response path­
ways that can contribute to health outcomes 
observed in population studies, only the last 
(lung function) has been commonly mea­
sured in the population studies undergird­
ing health­based air quality regulations. It is 
possible that some synergisms occurring at 
intermediate steps in pathogenic pathways 
may not be manifest in outcomes at the clini­
cal level. For many examples of synergism we 
identified, it is uncertain whether the syner­
gism would be manifest at clinical and public 
health scales. Effects at subclinical levels have 
provided supportive evidence for associations 
between air pollutants and health, but air 
quality regulations have been based generally 
on mortality and morbidity outcomes that 
are a consequence of the integrated actions 
of myriad molecular and cellular biological 
responses. The interpretation of the impli­
cations of synergistic effects on subclinical 
homeostatic and pathologic responses raises 
the possibly insoluble dilemma of defining 
at what level measured responses constitute 
adverse effects (American Thoracic Society 
2000). The present information offers only 
indirect evidence for synergies among pol­
lutants in morbidity or mortality caused or 
exacerbated by air pollutants.
Ideally, hypotheses related to synergism 
would be tested under real­world conditions 
in epidemiologic studies. However, several bar­
riers weaken the epidemiologic approach to 
investigating synergism. First, the exposures to 
the multiple pollutants of concern need to be 
estimated; this may prove difficult because of 
the complexity of estimating exposures to pol­
lutants as they vary spatially and temporally. 
Inaccuracies in exposure assessment will tend 
to decrease the sensitivity of a study for esti­
mating the degree of synergy. Second, unless a 
high degree of synergism is anticipated, study 
populations of substantial size are needed to 
characterize the combined effects of multiple 
agents because of the limited statistical power of 
the analytic methods used to assess synergism. It 
is impractical to test for synergisms in the popu­
lation as precisely as the laboratory permits. The 
composition of the environmental air pollution 
mixture varies in location and time, but the 
spatial–temporal variation generally does not 
provide the degree of exposure contrasts needed 
to compare effects of multiple pollutants alone 
and in combination. The effects of single pollut­
ants are generally inferred from such variations, 
but characterization of quantitative relationships 
is far more imprecise for the effects of combina­
tions of pollutants than for the effects of single 
pollutants. The precision of exposure estimates 
also poses a limitation. Accurate measures of 
personal exposures have only been linked to 
individual outcomes in panel studies of limited 
scope, and even then, no study has measured 
the full range of pollutant species to which the 
subjects were exposed. The weight of air pollu­
tion epidemiology necessarily rests largely on 
estimates of exposure derived from monitor­
ing data mandated by air quality regulations; 
thus, substantial data are available for only a few 
  pollutants and pollutant classes.
In this review we identified a need for 
more rigorous reporting of findings of studies 
that consider synergism. The term is widely 
and loosely used. Claims of synergism should 
be accompanied by the needed quantitative 
assessment of the evidence and preferably by 
an assessment of the precision with which 
synergism has been demonstrated. Our deter­
mination of whether synergism was dem­
onstrated in the studies we examined was 
semiquantitative and often based on graphs 
rather than numeric data. Reports of statisti­
cal significance were limited to differences 
between effects of combined and sham expo­
sures or between combined and single expo­
sures; the statistical significance with which 
combined exposures had greater than additive 
effects was not reported.
The results of this review indicate that 
synergies among environmental air pol­
lutants are plausible and that experimental 
approaches may document their existence. It 
is both plausible and widely accepted that few, 
if any, effects of air pollution are attributable 
to single pollutants exclusively, although both 
epidemiologic and laboratory findings indi­
cate that single pollutants or pollutant classes 
can dominate certain effects. Nonetheless, 
research strategies have been driven largely 
by single­pollutant, single­source regulatory 
frameworks, and thus have focused on detect­
ing and confirming the causality of single pol­
lutants or specific complex source emissions 
treated as a single exposure material. Very lim­
ited emphasis has been given to apportioning 
effects among the full spectrum of pollutants 
or evaluating pollutant interactions. A shift of 
the emphasis of air pollution health research 
toward a more comprehensive, forward­
thinking, multipollutant perspective would be 
timely in view of the increasing trend toward 
multipollutant regulatory strategies. Despite 
the limitations of laboratory and epidemio­
logic research tools, both approaches could 
plausibly be directed more toward a better 
understanding of the roles of a much broader 
spectrum of air contaminants, and thus their 
sources, to the health impacts associated statis­
tically with indices of air pollution. Although 
it is clearly impossible to study large numbers 
of pollutants using a full factorial study design, 
there are multiple strategies for disentangling 
the contributions of multiple pollutants in the 
laboratory (Mauderly 1993). The evaluation of 
synergies and antagonisms among pollutants, 
including their dose–response relationships, is 
a necessary foundation for progressing toward 
a multipollutant air quality management 
framework, as noted by the NRC Committee 
on Air Quality Management in the United 
States (NRC 2004b).
In summary, our selective review con­
firmed that synergisms (greater than additive 
effects) among air pollutants in causing mea­
surable biological effects have been demon­
strated in laboratory studies of humans and 
animals. The limited sample of studies encom­
passed by this review served to answer this 
question, and it might be expected that a more 
comprehensive review of the air pollution lit­
erature would reveal additional evidence. Our 
review also identified evidence for additive and 
less than additive responses to combined expo­
sures to multiple pollutants, sometimes among 
Appendix I. Potential 
  interactions among pollutants.
Additivity: effect of the combination equals 
the sum of individual effects.
Synergism: effect of the combination is 
greater than the sum of individual effects.
Antagonism: effect of the combination is less 
than the sum of individual effects.
Inhibition: a component having no effect 
reduces the effect of another component.
Potentiation: a component having no effect 
increases the effect of another component.
Masking: two components have opposite, 
cancelling effects such that no effect is 
observed from the combination.
“Effect” means the observed expression of the par­
ticular health outcome in question. A combination 
of pollutants could have different interactions for 
different outcomes. The interaction could occur at 
any level of biological pathway from exposure to 
expression of the outcome (U.S. EPA 2000).Mauderly and Samet
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different outcome measures in studies in 
which certain outcomes revealed synergisms, 
and sometimes among the same outcomes at 
different times after exposure. To our knowl­
edge, there has been no systematic review of all 
literature on the health effects of air pollution 
for evidence of pollutant interactions; thus, we 
have limited insight into the overall balance of 
the effects of the many possible combinations 
of pollutants. Although little, if any, evidence 
of synergisms has been developed at common 
environmental exposure levels, the possibility 
of both synergisms and antagonisms needs 
to be considered. In the absence of relevant 
evidence to the contrary, the assumption of 
additive effects appropriately remains the 
default for regulatory risk assessment purposes. 
However, considering the likelihood that both 
synergisms and antagonisms result from envi­
ronmental exposures and their importance 
to accurate assessments of risk, evaluations of 
pollutant interactions by both epidemiologic 
and laboratory research approaches will be 
critical for developing a stronger foundation 
for multipollutant air quality management. 
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